Información del producto
- Ck-1827452
- Methyl 4-[[2-fluoro-3-[N′-(6-methylpyridin-3-yl)ureido]phenyl]methyl]piperazine-1-carboxylate
- Omecamtiv mecarbil
CK 1827452O is a small-molecule drug that increases the glomerular filtration rate (GFR) by inhibiting the Na+,K+-ATPase. CK 1827452O has been shown to be effective in treating congestive heart failure, which may be due to its ability to increase cardiac output and reduce left ventricular end-diastolic pressure. CK 1827452O also acts on the cytosolic calcium concentration and systolic pressure, as well as natriuretic and inotropic drugs. These effects are due to its inhibition of Na+,K+-ATPase, which leads to an increase in intracellular calcium and an increase in cAMP levels.
Propiedades químicas
Consulta técnica sobre: 3D-FC103484 CK 1827452O
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
